PLURISTEM THERAPEUTICS
Pluristem Therapeutics is a clinical-stage biotechnology company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for a broad spectrum of diseases. Pluristem derives its cell products from human placental cells. These cells are converted into PLacental eXpanded (PLX) cells, which secrete therapeutic proteins in response to signals produced by damaged tissues. Pluristem’s pipeline targets multiple indications involving inflamm... ation and ischemia, including peripheral artery disease, muscle injury, preeclampsia, and graft versus host disease. PLX cells require no tissue matching prior to administration, making them an “off-the-shelf” product. The company’s GMP-certified in-house manufacturing facilities allow it to efficiently produce commercial quantities of homogeneous, clinical-grade PLX cells. Pluristem is currently the only company manufacturing large quantities of placenta-based cell products using a 3D bioreactor. Driving these development efforts is a management team dedicated to shaping the future of the company and of placenta-based cell therapies. The Pluristem team has many decades of industry and research experience and draws on this as it continues to progress towards company goals.
PLURISTEM THERAPEUTICS
Industry:
3D Technology Biotechnology Therapeutics
Founded:
2003-01-01
Address:
Haifa, Hefa, Israel
Country:
Israel
Website Url:
http://www.pluristem.com
Total Employee:
101+
Status:
Active
Contact:
+972-74-710-8600
Email Addresses:
[email protected]
Total Funding:
162.49 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail Gravity Forms Linode 012 Smile PandaDoc
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
HanBio Therapeutics
HanBio Therapeutics is a biotechnology company committed to researching and developing next generation transformative medicines.
Innovative Cellular Therapeutics
Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Shanghai Cell Therapy Group
Shanghai Cell Therapy Group is a provider of cellular diagnosis center combining cellular research and treatment services.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
European Investment Bank
European Investment Bank investment in Post-IPO Debt - Pluristem Therapeutics
Innovative Medical Management
Innovative Medical Management investment in Post-IPO Equity - Pluristem Therapeutics
Official Site Inspections
http://www.pluristem.com Semrush global rank: 5.71 M Semrush visits lastest month: 1.47 K
- Host name: pluri-biotech1.tempurl.host
- IP address: 107.191.40.71
- Location: Piscataway United States
- Latitude: 40.5511
- Longitude: -74.4606
- Metro Code: 501
- Timezone: America/New_York
- Postal: 08854
